Multinational firms showing lukewarm attitudes over direct dealing with Dongwon

Published: 2009-12-24 06:59:00

Updated: 2009-12-24 06:59:00

Most of foreign-invested pharmaceutical firms have opened their direct transactions with Dongwon Group’s affiliated wholesalers, but some of multinational companies are still inactive, according to market observers.

Currently, three multinational companies ― Novartis Korea, Boehringer Ingelhei...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK